| Next Step Orthopaedics Inc | |
| 331 Main St, West Orange, New Jersey 07052 | |
| (973) 736-2244 |
| Name | Next Step Orthopaedics Inc |
|---|---|
| Organization Name | Next Step Orthopaedics Inc |
| Location | 331 Main St, West Orange, New Jersey 07052 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (973) 736-2244 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Researchers at UC San Francisco (UCSF) have discovered that endostatin, a protein that once aroused intense interest as a possible cancer treatment, plays a key role in the stable functioning of the nervous system.
Scientists from the Florida campus of The Scripps Research Institute have won nearly $1.7 million from the National Institutes of Health's National Institute of Neurological Disorders and Stroke to investigate the mechanisms that contribute to Huntington's disease, a fatal inherited disease that some have described as having ALS, Parkinson's and Alzheimer's-at the same time.
The hematology journal BLOOD published today a full-length article describing final Phase 2 data for Symphogen's rozrolimupab, a novel human recombinant mixture of 25 antibodies which all are manufactured simultaneously from a single batch.
Scientists have shown for the first time that one of the sex chromosomes is involved in the development of a cancer that can afflict both genders, according to a Cancer Research UK-funded study in Nature Genetics.
AxioMed® Spine Corporation , a spinal orthopedics company focused on the development of products designed to restore spinal function in patients with degenerative spine disease by advancing the standard of care beyond fusion and first generation disc replacement, announced today that it has raised $14.5 million in two tranches from both current and new investors.
› Verified 5 days ago
| NPI Number | 1164593992 |
| Organization Name | NEXT STEP ORTHOPAEDICS, INC |
| Doing Business As | NEXT STEP ORTHOTICS & PROSTHETICS |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 331 Main St, West Orange, NJ 07052 |
| Phone Number | 973-736-2244 |
News Archive
Researchers at UC San Francisco (UCSF) have discovered that endostatin, a protein that once aroused intense interest as a possible cancer treatment, plays a key role in the stable functioning of the nervous system.
Scientists from the Florida campus of The Scripps Research Institute have won nearly $1.7 million from the National Institutes of Health's National Institute of Neurological Disorders and Stroke to investigate the mechanisms that contribute to Huntington's disease, a fatal inherited disease that some have described as having ALS, Parkinson's and Alzheimer's-at the same time.
The hematology journal BLOOD published today a full-length article describing final Phase 2 data for Symphogen's rozrolimupab, a novel human recombinant mixture of 25 antibodies which all are manufactured simultaneously from a single batch.
Scientists have shown for the first time that one of the sex chromosomes is involved in the development of a cancer that can afflict both genders, according to a Cancer Research UK-funded study in Nature Genetics.
AxioMed® Spine Corporation , a spinal orthopedics company focused on the development of products designed to restore spinal function in patients with degenerative spine disease by advancing the standard of care beyond fusion and first generation disc replacement, announced today that it has raised $14.5 million in two tranches from both current and new investors.
› Verified 5 days ago
| NPI Number | 1619228517 |
| Organization Name | NEXT STEP ORTHOPAEDICS, INC. |
| Type | Prosthetic/Orthotic Supplier |
| Address | 99 Beauvoir Avenue, Summit, NJ 07901 |
| Phone Number | 973-736-2244 |
News Archive
Researchers at UC San Francisco (UCSF) have discovered that endostatin, a protein that once aroused intense interest as a possible cancer treatment, plays a key role in the stable functioning of the nervous system.
Scientists from the Florida campus of The Scripps Research Institute have won nearly $1.7 million from the National Institutes of Health's National Institute of Neurological Disorders and Stroke to investigate the mechanisms that contribute to Huntington's disease, a fatal inherited disease that some have described as having ALS, Parkinson's and Alzheimer's-at the same time.
The hematology journal BLOOD published today a full-length article describing final Phase 2 data for Symphogen's rozrolimupab, a novel human recombinant mixture of 25 antibodies which all are manufactured simultaneously from a single batch.
Scientists have shown for the first time that one of the sex chromosomes is involved in the development of a cancer that can afflict both genders, according to a Cancer Research UK-funded study in Nature Genetics.
AxioMed® Spine Corporation , a spinal orthopedics company focused on the development of products designed to restore spinal function in patients with degenerative spine disease by advancing the standard of care beyond fusion and first generation disc replacement, announced today that it has raised $14.5 million in two tranches from both current and new investors.
› Verified 5 days ago
| NPI Number | 1659442374 |
| Type | Prosthetic/Orthotic Supplier |
| Address | 331 Main St, East Orange, NJ 07017 |
| Phone Number | 973-736-2244 |
News Archive
Researchers at UC San Francisco (UCSF) have discovered that endostatin, a protein that once aroused intense interest as a possible cancer treatment, plays a key role in the stable functioning of the nervous system.
Scientists from the Florida campus of The Scripps Research Institute have won nearly $1.7 million from the National Institutes of Health's National Institute of Neurological Disorders and Stroke to investigate the mechanisms that contribute to Huntington's disease, a fatal inherited disease that some have described as having ALS, Parkinson's and Alzheimer's-at the same time.
The hematology journal BLOOD published today a full-length article describing final Phase 2 data for Symphogen's rozrolimupab, a novel human recombinant mixture of 25 antibodies which all are manufactured simultaneously from a single batch.
Scientists have shown for the first time that one of the sex chromosomes is involved in the development of a cancer that can afflict both genders, according to a Cancer Research UK-funded study in Nature Genetics.
AxioMed® Spine Corporation , a spinal orthopedics company focused on the development of products designed to restore spinal function in patients with degenerative spine disease by advancing the standard of care beyond fusion and first generation disc replacement, announced today that it has raised $14.5 million in two tranches from both current and new investors.
› Verified 5 days ago
| NPI Number | 1760553473 |
| Type | Prosthetic/Orthotic Supplier |
| Address | 331 Main St, East Orange, NJ 07017 |
| Phone Number | 973-736-2244 |
News Archive
Researchers at UC San Francisco (UCSF) have discovered that endostatin, a protein that once aroused intense interest as a possible cancer treatment, plays a key role in the stable functioning of the nervous system.
Scientists from the Florida campus of The Scripps Research Institute have won nearly $1.7 million from the National Institutes of Health's National Institute of Neurological Disorders and Stroke to investigate the mechanisms that contribute to Huntington's disease, a fatal inherited disease that some have described as having ALS, Parkinson's and Alzheimer's-at the same time.
The hematology journal BLOOD published today a full-length article describing final Phase 2 data for Symphogen's rozrolimupab, a novel human recombinant mixture of 25 antibodies which all are manufactured simultaneously from a single batch.
Scientists have shown for the first time that one of the sex chromosomes is involved in the development of a cancer that can afflict both genders, according to a Cancer Research UK-funded study in Nature Genetics.
AxioMed® Spine Corporation , a spinal orthopedics company focused on the development of products designed to restore spinal function in patients with degenerative spine disease by advancing the standard of care beyond fusion and first generation disc replacement, announced today that it has raised $14.5 million in two tranches from both current and new investors.
› Verified 5 days ago
News Archive
Researchers at UC San Francisco (UCSF) have discovered that endostatin, a protein that once aroused intense interest as a possible cancer treatment, plays a key role in the stable functioning of the nervous system.
Scientists from the Florida campus of The Scripps Research Institute have won nearly $1.7 million from the National Institutes of Health's National Institute of Neurological Disorders and Stroke to investigate the mechanisms that contribute to Huntington's disease, a fatal inherited disease that some have described as having ALS, Parkinson's and Alzheimer's-at the same time.
The hematology journal BLOOD published today a full-length article describing final Phase 2 data for Symphogen's rozrolimupab, a novel human recombinant mixture of 25 antibodies which all are manufactured simultaneously from a single batch.
Scientists have shown for the first time that one of the sex chromosomes is involved in the development of a cancer that can afflict both genders, according to a Cancer Research UK-funded study in Nature Genetics.
AxioMed® Spine Corporation , a spinal orthopedics company focused on the development of products designed to restore spinal function in patients with degenerative spine disease by advancing the standard of care beyond fusion and first generation disc replacement, announced today that it has raised $14.5 million in two tranches from both current and new investors.
› Verified 5 days ago
American Medical Equipment Supplies Type: DME Supplier - Customized Equipment Location: 480 Valley Rd, West Orange, New Jersey 07052 Phone: (862) 233-7293 | |
Hanger Clinic Type: Durable Medical Equipment & Medical Supplies Supplier Location: 59 Main St, West Orange, New Jersey 07052 Phone: (973) 736-0628 | |
Cvs Pharmacy # 02813 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 217 Main St, West Orange, New Jersey 07052 Phone: (973) 325-5690 | |
Cvs Pharmacy #00687 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 20 S Valley Rd, West Orange, New Jersey 07052 Phone: (973) 243-7015 | |
Cvs Pharmacy #10087 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 265 Prospect Ave, West Orange, New Jersey 07052 Phone: (973) 243-7008 |